Company news
Bora Pharmaceuticals Co Ltd (TWSE:6472) news
Bora Pharmaceuticals Co Ltd news releases on 6ix. Latest, Sep 30, 2026: UPSHER-SMITH LAUNCHES FLUVOXAMINE MALEATE EXTENDED-RELEASE CAPSULES
Press releases & updates
UPSHER-SMITH LAUNCHES FLUVOXAMINE MALEATE EXTENDED-RELEASE CAPSULES
September 30, 2026
Insilico Medicine and Bora Pharmaceuticals Announce Strategic Alliance for AI-Driven Drug Discovery and Development
July 13, 2026
Bora Pharmaceuticals : Announcement on the Company's resolution on cash dividend date（correction and additional Information on Items 12 to 16）
July 6, 2026
Bora Pharmaceuticals Completes Acquisition of MacroGenics' Rockville Manufacturing Operations
July 2, 2026
UPSHER-SMITH EXPANDS KYMBEE™ (DEFLAZACORT) FAMILY OF PRODUCTS WITH LAUNCH OF ORAL SUSPENSION FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY
June 23, 2026
Bora Pharmaceuticals : Announce on behalf of material subsidiary Bora Pharmaceutical Holdings, LLC. to acquire the product licenses and rights
June 18, 2026
UPSHER-SMITH LAUNCHES NEW ONLINE RESOURCES TO SUPPORT THE DUCHENNE COMMUNITY
April 14, 2026
UPSHER-SMITH LAUNCHES GENERIC VERSION OF CIPRODEX® (CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1%) STERILE OTIC SUSPENSION
April 6, 2026
Bora Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12th
March 3, 2026
Bora Pharmaceuticals and GSK Sign $250M Five Year Global Manufacturing Contract
February 23, 2026
OTC Markets Group Welcomes Bora Pharmaceuticals Co., Ltd. to OTCQX
January 7, 2026
Bora Pharmaceuticals and Corealis Pharma Forge Strategic Alliance to Deliver Seamless, End-to-End Oral Solid Dose Development
December 9, 2025
Bora Pharmaceuticals Announces Multi-Year Expansion for Midwest Manufacturing Site, as Upsher-Smith Entity Split is Finalized
August 5, 2025
Bora Pharmaceuticals to Expand Rare Disease Portfolio with Acquisition of US-Based Pyros Pharmaceuticals
October 25, 2024
Bora Pharmaceuticals : The Company's Board of Director's resolution on the execution of syndicated loan
August 12, 2022
Bora Pharmaceuticals : The Company's Board of Director's resolution on the Company's 2022 Q2 financial statement
August 12, 2022
Bora Pharmaceuticals : The Company's Board of Director's resolution on ex-rights date
August 12, 2022
Bora Pharmaceuticals : The Board of Director's resolution on not distributing dividend for first half of 2022
August 12, 2022
Bora Pharmaceuticals : Announcement on the Company's resolution on cash dividend date(additional information)
June 27, 2022
Bora Pharmaceuticals : Announcement on the Company's resolution on cash dividend date
June 22, 2022
Bora Pharmaceuticals : The Company's stock has reached the announcement criteria several times recently. The below information is published for investor's information
June 22, 2022
Bora Pharmaceuticals : Announcement on behalf of the material subsidiary, Bora Pharmaceutical Laboratories Inc., for the Board resolution on cash dividend date
June 21, 2022
Bora Pharmaceuticals : To announce the Company to acquire 100% common share of TWi Pharmaceuticals, Inc.
June 14, 2022
Bora Pharmaceuticals : To announce the press release for the Company's press conference on material information today
June 14, 2022
Bora Pharmaceuticals : The Company's Board of Director's resolution on convening 2022 1st extraordinary stockholder meeting
June 14, 2022
Bora Pharmaceuticals : The Company's Board of Directors passes the reolution to increase cash capital for the subsidiary
June 14, 2022
Bora Pharmaceuticals : The Company's Board of Director's resolution on issung 2nd domestic unsecured convertible corporate bonds
June 14, 2022
Bora Pharmaceuticals : To announcement the Company to hold a material information press conference on June 14, 2022
June 14, 2022
Bora Pharmaceuticals : The Company's shareholder's resolution to discharge the director's non-compete clause
May 23, 2022
Bora Pharmaceuticals : Announce on the Company's resolution for 2021 annual general shareholders' meeting
May 23, 2022
Bora Pharmaceuticals : To announce in accordance with Article 25.1(3) of the Regulations Governing Loaning of Funds and Making of Endorsements/Guarantees by Public Companies
April 11, 2022
Bora Pharmaceuticals : The Company's announcement to the creditor due to the spin off
April 11, 2022
Bora Pharmaceuticals : Announcement on behalf of the material subsidiary, Bora Bora Pharmaceutical Laboratories Inc., for the Board resolution on cash capital increase
April 11, 2022